Thrombopoietin and Its Alternatively Spliced Form Are Expressed in Human Amygdala and Hippocampus

To the Editor:
Thrombopoietin (TPO) is a newly cloned and characterized cytokine that stimulates megakaryocytopoiesis and platelet production.'" Recent studies have shown that TPO speeds up platelet recovery after cytoreductive the rap^^,^ and, thus, holds great potential for the treatment of thrombocytopenia of various etiologies. Human mature TPO is composed of 353 amino acids. The N-terminal 153 amino acid sequence of TPO is highly conserved among the mouse, pig, and human and shares a significant homology with erythropoietin (EPO), a hematopoietic growth factor stimulating red blood cell production. In fact, the product derived from the N-terminal 153 amino acid sequence of TPO is fully functionaL2 However, further deletion of this 153 amino acid peptide at the C-terminus results in nonfunctional TPO derivatives.6 Recently, we have noticed that a 39 amino acid stretch within TPO's N-terminal half shares a significant homology with neurotrophins.' A TPO expression is easily detectable in kidney and livery an expression pattern similar to that of EPO. However, TPO transcripts are also detected in skeletal muscle, with lesser amounts present in the spleen and bone marrow? In the kidney, there exists an alternatively spliced form (TP02) of TPO with a 4 amino acid deletion within the N-terminal portion. This deletion is conserved between the pig, mouse, and human? In this study, we report that TPOspecific transcripts were also detectable in the brain, placenta, and several cell lines, including human rhabdomyosarcoma cell line RD and human leukemia cell lines UT-7EPO and HEL, as analyzed by reverse transcriptase-mediated polymerase chain reaction (RT-PCR) followed by Southern blotting. In addition, we showed that both TPO and TP02 transcripts were coexpressed in the brain as well as in the kidney, as shown by DNA sequence analysis of PCR products.
Furthermore. we found that TPO-specific transcripts were abundantly expressed, as detected on a human brain multiple tissue Northem blot, in the amygdala and hippocampus, whereas little, if any, 
primers.
I :
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From TPO transcripts were detected in other parts of the brain, such as the caudate nucleus, corpus callosum, hypothalamus, substantia nigra, subthalamic nucleus, and thalamus.
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RT-PCR was performed using a Superscript preamplification system purchased from GlBCOlBRL (Grand Island. NY) on RNAs isolated from tissues and cell lines as described in Fig 1. The first strand cDNAs obtained were amplified with upstream and downstream TPO-specific primers synthesized by the University core facility. The upstream TPO-specific PCR primer, S'GTAAACTGC-TCGTGACTCC 3'. corresponds to positions 316 to 335 of the sequence with GenBank accession number L33410 and the downstream primer, S'GTTGGAAGCTCAGGAAGATG 3'. corresponds to positions 675 to 656 of the same sequence. The conditions for PCR were 94°C denaturation for I minute, 60°C annealing for I minute, and 72°C polymerization for 1 minute for a total of 30 cycles, with a final extension at 72°C for IO minutes. Aliquots of 15 pL of PCR products were fractionated on a I .S% agarose gel. Figure I A showed that there existed a major PCR product of about 359 bp in samples used for analysis. High stringency"' Southern blotting analysis using TPO cDNA labeled with "P as a probe were from the following brain tissues: 1, amygdala; 2, caudate nucleus; 3, corpus callosum; 4, hippocampus; 5, hypothalamus; 6, substantia nigra; 7, subthalamic nucleus; and 8, thalamus. Note that the TPO-specific messages was detected only in the amygdala and hippocampus. (B) The same blot was stripped and reprobed with a cDNA fragment corresponding to tif, a brain-expressed gene.
Tpo -
tif -
showed (Fig 1) that the major PCR products were all TPO-specific. The 359-bp fragments (Fig IA) were eluted from brain and kidney samples using Geneclean (Bio 101, Inc, Vista, CA) and cloned into pT7 Blue(R) T-vector (Novagen, Madison, WI). Plasmid DNA was purified from randomly selected positive clones and sequenced. DNA sequencing analyses showed that both TPO and TPO2 transcripts were coexpressed in the brain as well as in the kidney. Figure  2 shows a portion of original sequencing data that showed the deletion of 12 nucleotide residues in RT-PCR samples derived from human brain mRNA.
The level of TP02 transcript in these two tissues are surprisingly high, although the ratio (TPO2mPO) of these two forms of transcripts was significantly different in the brain (0.75) from that in the kidney (0.4).
In the original report of TPO cloning, TPO transcripts were not detected in the whole human brain,'.' which is apparently inconsistent with our RT-PCR findings. There were two plausible explanations for this discrepancy: ( I ) TPO is expressed at a low level in brain and, thus, is beyond the sensitivity of the Northern blotting technique, and (2) TPO is expressed only in a limited number of locations in the brain and the TPO-specific signal was diluted out in the whole brain RNA extracts. To differentiate the two possibilities, we probed a human brain multiple tissue Northern blot obtained from Clontech (Palo Alto, CA) with a full-length TPO cDNA probe labeled with '2P. The blot was washed according to the method described by Caplen and Gupta,'" followed by autoradiography. A TPO mRNA was detected in the amygdala and hippocampus ( Fig  3A. lanes I and 4) . but not in RNA samples derived from other parts of the brain. As a control, the same blot was stripped and probed with a cDNA fragment of rif; a gene known to be expressed in brain." The results were shown in Fig 3B. indicating that tifwas expressed in varying levels in all parts of the brain analyzed.
In summary, our data showed that TPO was expressed in a wider range of tissues than previously reported. In various brain tissues examined, TPO transcripts were detectable only in the amygdala and hippocampus, which are functionally important in short-term memory, learning, and emotional reactions. It is known that TPO specifically regulates megakaryocyte development and therefore promotes platelet production. Clinically, a decreased platelet count in circulating blood would render patients at risk of uncontrolled bleeding. Although the precise role for TPO expression in the amygdala and hippocampus of the brain remains unknown, it is possible that 
